Lecture 8: Chemical Messengers and Signal Transduction

Overview of Intercellular Communication

  • Direct Communication:

    • Mediated via gap junctions.

    • Structure: Transmembrane protein complexes called connexons form direct channels between adjacent cells, enabling the free passage of small ions and small water-soluble molecules.

    • Physiological Examples:

    • Muscle cells (such as cardiac muscle and smooth muscle of internal organs): electrically and metabolically coupled to contract together as a coordinated functional unit.

    • Specialized glands and neurons in the brain and retina: utilize gap junctions to achieve synchronized electrical and chemical communication.


    Direct communication through gap junctions and chemical messenger communication
  • Indirect Communication:

    • Mediated via chemical messengers synthesized and released by a secretory cell into the interstitial fluid.

    • Mechanism: The chemical messenger diffuses across the extracellular environment and selectively binds to a target cell receptor, initiating intracellular signal transduction pathways that induce a specific cellular response.

    • Response Magnitude: The strength of the target cell response generally increases as the number of bound receptors increases.

Functional Classifications of Chemical Messengers

  • Paracrines:

    • Communicate locally with neighboring cells by diffusing through the interstitial fluid.

    • Major Subclasses & Functional Roles:

    • Growth factors: Proteins that stimulate cellular proliferation and differentiation.

    • Clotting factors: Proteins that coordinate the coagulation cascade to stimulate blood clot formation.

    • Cytokines: Peptides typically secreted by immune cells to coordinate local and systemic defense responses against infection.

    • Autocrines:

    • A specialized functional subclass of paracrines.

    • Act directly on the specific cell that secreted them.


    Paracrine signaling between a secretory cell and a neighboring target cell
  • Neurotransmitters:

    • Released by neurons directly from axon terminals across a specialized synaptic junction.

    • Presynaptic neuron: Synthesizes and releases the neurotransmitter into the synaptic cleft.

    • Postsynaptic cell: Target cell possessing specific receptors (can be another neuron, a muscle cell, or a gland cell).


    Neurotransmitter release from an axon terminal into a synapse to target cell receptors
  • Hormones:

    • Secreted by endocrine glands (or specialized endocrine cells) into the interstitial fluid, where they diffuse into blood vessels.

    • Transported long distances throughout the circulatory system to interact with distant target cells containing matching receptors.

    • Neurohormones: A specialized class of hormones released by neurosecretory cells directly into the bloodstream; release mechanism is structurally similar to neurotransmitter secretion.


    Hormone secretion into a blood vessel and transport to target cell receptors

Chemical Classifications of Chemical Messengers

  • Biophysical Properties:

    • Lipophilic (Hydrophobic): Lipid-soluble molecules that readily cross plasma membrane lipid bilayers. Poorly soluble in aqueous plasma, requiring transport carrier proteins in the bloodstream.

    • Lipophobic (Hydrophilic): Water-soluble molecules that dissolve easily in blood plasma but cannot freely cross plasma membrane lipid bilayers.

  • Five Primary Chemical Classes:

    • Amino Acid Messengers:

    • Function exclusively as neurotransmitters within the brain and spinal cord.

    • Must be synthesized within the specific neuron that secretes them.

    • Chemical Property: Lipophobic (hydrophilic).

    • Key Examples: Glycine, Gamma-Aminobutyric acid (GABA), Glutamate, Aspartate.

    • Amine Messengers:

    • Derived biochemically from amino acids.

    • Synthesized within the cytosol of secretory cells.

    • Chemical Property: Most are lipophobic (hydrophilic).

    • Functional Classifications: Paracrines, neurotransmitters, and hormones.

    • Catecholamine Biosynthetic Pathway:

      1. Tyrosine (in cytosol) is converted by Tyrosine β\beta-hydroxylase into L-Dihydroxyphenylalanine (L-dopa).

      2. L-dopa is converted by Dopa decarboxylase into Dopamine.

      3. Dopamine is transported into storage vesicles and converted by Dopamine β\beta-hydroxylase into Norepinephrine.

      4. Norepinephrine returns to the cytosol in epinephrine-secreting cells and is converted by Phenylethanolamine N-methyl transferase (PNMT) into Epinephrine.


    Biosynthetic pathway of catecholamines from tyrosine to epinephrine
    • Peptide / Protein Messengers:

    • Constitute the vast majority of chemical messengers in the body, ranging from short peptides (33 amino acids) to large proteins (100+100+ amino acids).

    • Chemical Property: Lipophobic (hydrophilic).

    • Functional Classifications: Paracrines, neurotransmitters, and hormones.

    • Biosynthesis and Processing Steps:

      1. Translation: mRNA is translated into a prepropeptide precursor on ribosomes bound to the rough endoplasmic reticulum (RER).

      2. RER Processing: The signal peptide is cleaved inside the RER lumen, yielding a propeptide.

      3. Vesicular Transport: Propeptides are transported via vesicles from the smooth ER to the Golgi apparatus.

      4. Golgi Processing & Packaging: The Golgi apparatus packages propeptides into secretory vesicles.

      5. Cleavage in Secretory Vesicles: Proteolytic enzymes within secretory vesicles cleave propeptides into active peptide messengers and inactive amino acid fragments.

      6. Exocytosis: Upon stimulation, vesicles fuse with the plasma membrane to release active peptides into the extracellular fluid.


    Synthesis and processing pathway of peptide messengers
    • Steroid Messengers:

    • Derived structurally from cholesterol.

    • Chemical Property: Lipophilic (hydrophobic).

    • Storage & Synthesis: Cannot be stored in secretory vesicles because they cross membranes freely; synthesized on demand.

    • Functional Classifications: Hormones.

    • Steroid Synthetic Pathways:

      • Cholesterol →\rightarrow Nonactive intermediates →\rightarrow Progesterone.

      • Progesterone →\rightarrow Nonactive intermediates →\rightarrow Corticosterone →\rightarrow Aldosterone.

      • Progesterone →\rightarrow Nonactive intermediates →\rightarrow Cortisol.

      • Cholesterol →\rightarrow Dehydroepiandrosterone →\rightarrow Androstenedione.

      • Androstenedione →\rightarrow Testosterone or Estrone.

      • Testosterone →\rightarrow Dihydrotestosterone or Estradiol.

      • Estrone →\rightarrow Estradiol →\rightarrow Estriol.


    Biosynthetic pathway of steroid hormones from cholesterol
    • Eicosanoid Messengers:

    • Lipids synthesized by virtually all cells in the body from cell membrane phospholipids.

    • Chemical Property: Lipophilic (hydrophobic); synthesized on demand.

    • Functional Classifications: Paracrines.

    • Physiological Roles: Mediate inflammation, fever, blood clotting, and pain sensation.

    • Metabolic Pathways & Pharmacological Targets:

      • Phospholipase A2\text{A}_2 converts membrane phospholipids into Arachidonic acid.

      • Cyclooxygenase (COX) Pathway: Converts arachidonic acid into Prostaglandins, Prostacyclins, and Thromboxanes.

      • Lipoxygenase Pathway: Converts arachidonic acid into Leukotrienes.

      • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs, e.g., Aspirin): Target and inhibit enzymes involved in eicosanoid synthesis (COX), reducing pain and inflammation; aspirin also inhibits thromboxane synthesis to decrease blood clotting.


    Eicosanoid synthesis pathways from membrane phospholipids

Transport of Messengers in Blood

  • Hydrophilic (Lipophobic) Messengers:

    • Secreted from endocrine cells into extracellular fluid via exocytosis.

    • Dissolve directly in blood plasma and travel in free form to target tissues.

  • Hydrophobic (Lipophilic) Messengers:

    • Secreted from endocrine cells by simple diffusion across the plasma membrane.

    • Circulate in blood primarily bound to carrier proteins (>99%>99\% bound, <1%<1\% free hormone).

    • Dynamic Equilibrium: Only free hormone can leave blood capillaries and bind target receptors. As free hormone exits plasma, carrier proteins release additional bound hormone to maintain equilibrium.


    Comparison of blood transport mechanisms for hydrophilic and hydrophobic messengers

Receptor Properties and Signal Transduction Factors

  • Receptor Specificity and Affinity:

    • Specificity: Receptors bind selectively to only one specific messenger or structural class of messengers.

    • Affinity: The strength with which a receptor binds its messenger ligand. A single messenger molecule can bind to multiple receptor types, but each receptor type can exhibit a different affinity.

  • Determinants of Target Cell Response Magnitude:

    • Signal Transduction: A multistep intracellular cascade that converts extracellular receptor binding into a cellular response.

    • Response magnitude depends on three key factors:

    1. Messenger Concentration:

      • Response magnitude increases as messenger concentration [M][M] increases.

      • Saturation: Occurs when 100%100\% of available receptors are bound to messengers, producing a maximal cellular response.


      Receptor binding saturation curve showing percentage bound vs messenger concentration
    2. Number of Receptors Present:

      • Dynamic receptor density changes via receptor protein synthesis and degradation/turnover.

      • Up-Regulation: An increase in receptor density compared to normal levels.

        • Triggered when target cells are exposed to abnormally low messenger concentrations for a prolonged period.

        • Target cells adapt by becoming hyper-responsive to available messenger.

        • Clinical Example (Hypothyroidism): Synthetic hormone therapy is introduced in gradually increasing doses over time. This phased dosing allows time for down-regulation of hyper-sensitive receptors, preventing dangerous hypersensitivity reactions that would occur if the full therapeutic dose were administered initially.


      Effect of receptor concentration on total number of receptors bound
    3. Receptor Affinity:

      • At a given messenger concentration [M][M], receptors with higher affinity exhibit a higher percentage of bound receptors compared to low-affinity receptors.


      Comparison curve between high-affinity and low-affinity receptor binding

Receptor Agonists and Antagonists

  • Ligand Definition: Any molecule that binds selectively to a target receptor site.

  • Receptor Agonists:

    • Ligands that bind to a receptor and activate it, triggering a biological response.

    • Example: Morphine is an opioid agonist that binds to opioid receptors in the brain and spinal cord, mimicking endogenous opioids to block pain signal transmission.

  • Receptor Antagonists:

    • Ligands that bind to a receptor site but produce no biological response.

    • Competitively occupy receptor sites to block natural agonists from binding, thereby suppressing normal cellular activity.


    Diagram of receptor agonist and antagonist mechanisms on cell membrane

Signal Transduction Mechanisms: Intracellular Receptors

  • Target Location: Receptors for lipophilic messengers reside within the cytosol or nucleus of target cells.

  • Detailed Step-by-Step Pathway:

    1. Lipophilic messenger diffuses across the plasma membrane into the cytosol.

    2. Messenger binds to a cytoplasmic or nuclear receptor, forming a hormone-receptor complex.

    3. The hormone-receptor complex enters the nucleus (if formed in cytosol) and binds to specific DNA sequences called Hormone Response Elements (HREs).

    4. Binding to the HRE alters gene transcription, initiating or altering mRNA synthesis.

    5. mRNA exits the nucleus through nuclear pores into the cytoplasm.

    6. Ribosomes translate mRNA into specific proteins that alter cellular function.

  • Time Course: Because alterations require protein synthesis, physiological effects take hours to days to fully develop.


  • Intracellular receptor signal transduction pathway for lipophilic messengers

Signal Transduction Mechanisms: Membrane-Bound Receptors

  • Overview: Lipophobic messengers cannot cross the plasma membrane; their binding sites face the extracellular fluid. Receptors fall into three general functional classes:

  • 1. Channel-Linked Receptors (Ligand-Gated Ion Channels):

    • Alter membrane ion permeability upon ligand binding.

    • Fast Ligand-Gated Channels:

    • Receptor and ion channel are components of the same membrane protein.

    • Binding opens the channel directly, allowing specific ions (Na+\text{Na}^+, K+\text{K}^+, Cl−\text{Cl}^-) to flow across the membrane and rapidly change electrical properties of the cell.


    Fast ligand-gated ion channel mechanism on plasma membrane
    • Calcium Channels:

    • Ligand binding opens calcium channels, allowing Ca2+\text{Ca}^{2+} influx into the cytosol.

    • Ca2+\text{Ca}^{2+} acts directly as a second messenger to alter electrical properties, trigger muscle contraction, or induce secretion, or binds Calmodulin. The Ca2+\text{Ca}^{2+}-Calmodulin complex activates protein kinases to phosphorylate functional target proteins.


    Calcium channel linked receptor pathway and calmodulin activation
    • Slow Ligand-Gated Channels:

    • Receptor and ion channel are separate membrane proteins coupled indirectly via G proteins.

  • 2. Enzyme-Linked Receptors:

    • Receptor binding site and enzymatic active site are located on the same protein structure.

    • Binding site faces interstitial fluid; enzymatic active site faces cytosol.

    • Tyrosine Kinase Receptors:

    1. Messenger binds to extracellular receptor domain.

    2. Receptor undergoes conformational activation / dimerization.

    3. Active tyrosine kinase domain phosphorylates target protein tyrosine residues using ATP:        Protein-Tyr+ATP→Protein-Tyr-P+ADP\text{Protein-Tyr} + \text{ATP} \rightarrow \text{Protein-Tyr-P} + \text{ADP}

    4. Phosphorylated proteins execute cellular responses (altering metabolic processes or protein synthesis).


    Tyrosine kinase enzyme-linked receptor signaling mechanism

G Protein-Linked Receptors and Second Messenger Systems

  • G Protein Structure & Activation Cycle:

    • G proteins are heterotrimers bound to the intracellular side of the plasma membrane, composed of alpha (α\alpha), beta (β\beta), and gamma (γ\gamma) subunits.

    • Unstimulated State: The α\alpha subunit binds Guanosine Diphosphate (GDP) and remains complexed with βγ\beta\gamma subunits.

    • Activation Step: Messenger binding to GPCR induces nucleotide exchange, releasing GDP from the α\alpha subunit and replacing it with Guanosine Triphosphate (GTP).

    • Activated State: α-GTP\alpha\text{-GTP} subunit dissociates from the βγ\beta\gamma dimer. Both α-GTP\alpha\text{-GTP} and βγ\beta\gamma complexes diffuse laterally along the membrane to interact with effector proteins (ion channels or amplifier enzymes).

    • Termination Step: Intrinsic GTPase activity of the α\alpha subunit hydrolyzes GTP back to GDP and inorganic phosphate (Pi\text{P}_i), allowing reassociation into the inactive αβγ-GDP\alpha\beta\gamma\text{-GDP} complex.


    G protein activation cycle from unstimulated state to activated state
  • Adenylate Cyclase / Cyclic AMP (cAMP) System:

    1. Messenger binds to G protein-linked receptor.

    2. G protein is activated via nucleotide exchange (GTP\text{GTP} replaces GDP\text{GDP} on α\alpha subunit).

    3. Active α-GTP\alpha\text{-GTP} activates the amplifier enzyme Adenylate Cyclase.

    4. Adenylate Cyclase converts cytosolic ATP into Cyclic Adenosine Monophosphate (cAMP).

    5. cAMP activates Protein Kinase A (PKA).

    6. Active PKA phosphorylates specific target proteins:      Protein+ATP→Protein-P+ADP\text{Protein} + \text{ATP} \rightarrow \text{Protein-P} + \text{ADP}

    7. Phosphorylated proteins produce the final cellular response.


    Adenylate cyclase second messenger signal transduction pathway
  • Phosphatidylinositol System (PIP2\text{PIP}_2 / PLC Pathway):

    1. Messenger binds to G protein-linked receptor.

    2. G protein is activated via GTP\text{GTP} exchange on the α\alpha subunit.

    3. Active α-GTP\alpha\text{-GTP} activates the amplifier enzyme Phospholipase C (PLC).

    4. Phospholipase C cleaves membrane phospholipid Phosphatidylinositol 4,5-bisphosphate (PIP2\text{PIP}_2) into two second messengers:

    • Diacylglycerol (DAG): Remains in plasma membrane, activating Protein Kinase C (PKC). PKC phosphorylates proteins (Protein+ATP→Protein-P+ADP\text{Protein} + \text{ATP} \rightarrow \text{Protein-P} + \text{ADP}) to induce cellular responses.

    • Inositol Trisphosphate (IP3\text{IP}_3): Water-soluble molecule that diffuses into cytosol and binds to IP3\text{IP}_3-gated calcium channels on endoplasmic reticulum (ER) membranes.

    1. IP3\text{IP}_3 opens ER channels, releasing stored Ca2+\text{Ca}^{2+} into cytosol.

    2. Elevated cytosolic Ca2+\text{Ca}^{2+} directly induces cell responses (contraction, secretion) or binds Calmodulin to activate protein kinase pathways leading to protein phosphorylation and altered cell function (contraction, metabolism, transport).


    Phospholipase C second messenger system producing IP3 and DAG

Signal Amplification by Second Messengers

  • Multi-Tier Cascades:

    • Signal amplification occurs when a single extracellular messenger molecule triggers a multi-step enzymatic cascade, producing millions of active intracellular end-products.

  • Step-by-Step Quantitative Amplification Breakdown:

    • 11 extracellular messenger molecule binds to 11 GPCR receptor.

    • Receptor activates approximately 1010 G proteins.

    • Each active G protein subunit activates 11 Adenylate Cyclase enzyme (total of 1010 Adenylate Cyclase enzymes).

    • Each Adenylate Cyclase enzyme synthesizes hundreds of cAMP molecules (total of 5,0005{,}000 cAMP molecules generated).

    • Each cAMP molecule activates 11 Protein Kinase A (PKA) enzyme (total of 5,0005{,}000 PKA enzymes activated).

    • Each active Protein Kinase A enzyme phosphorylates hundreds of target proteins (total of 2,500,0002{,}500{,}000 phosphorylated proteins produced).

  • Net Outcome: Binding of a single messenger molecule at the cell surface leads to the phosphorylation of millions of target proteins inside the cell.


  • Quantitative signal amplification cascade diagram for G protein second messenger pathways